Edition:
United Kingdom

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

6.27USD
22 Oct 2018
Change (% chg)

$-0.52 (-7.66%)
Prev Close
$6.79
Open
$6.76
Day's High
$6.79
Day's Low
$6.12
Volume
106,119
Avg. Vol
130,833
52-wk High
$15.12
52-wk Low
$5.59

Chart for

About

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet needs. Its development pipeline includes two product candidates: ZYN002 and ZYN001. ZYN002 is a synthetic cannabidiol (CBD), which... (more)

Overall

Beta: --
Market Cap(Mil.): $128.07
Shares Outstanding(Mil.): 13.26
Dividend: --
Yield (%): --

Financials

  ZYNE.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -2.62 -- --
ROI: -55.80 0.21 14.27
ROE: -55.80 1.17 15.99

BRIEF-Zynerba Pharmaceuticals Reports Q1 Loss Of $0.91 Per Share

* ZYNERBA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

08 May 2018

BRIEF-Zynerba Pharmaceuticals Says ZYN002 Was Shown To Be Well Tolerated Through 12 Months Of Treatment In Star 2 Study

* ZYNERBA PHARMACEUTICALS SAYS ZYN002 WAS SHOWN TO BE WELL TOLERATED THROUGH 12 MONTHS OF TREATMENT IN STAR 2

25 Apr 2018

Earnings vs. Estimates